Baxter International Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2025: -7.58%

Baxter International Inc. Return on Equity (ROE) is -7.58% for the Trailing 12 Months (TTM) ending March 31, 2025, a -121.63% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Baxter International Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2024 was 35.03%, a -192.95% change year over year.
  • Baxter International Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2023 was -37.69%, a -415.73% change year over year.
  • Baxter International Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2022 was 11.94%, a -5.45% change year over year.
  • Baxter International Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2021 was 12.63%, a -1.32% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share